// App-Quantinova.ai

OP17 : A molecular measure of inflammation in IBD patients based on transcriptional profiles from 2495 intestinal biopsies

Researchers

Presenter

  • R Huang

Principal Investigators

  • R Kosoy

  • W-m Song

  • A Dinarzo

  • K Hao

  • J Rogers

  • A Atreja

  • M Mahajan

  • A Stojmirovic

  • J Perrigoue

  • C Brodmerkel

  • S Plevy

  • J Friedman

  • J-F Colombel

  • M Dubinsky

  • B Sands

  • E Schadt

  • A Kasarskis

  • B Losic

  • C Argmann

  • M Suarez-Farinas

Medical Centers

  • Icahn School at Mount Sinai, Department of Population, Health Science and Policy, New York, USA

  • University College London, London, UK

  • Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, New York, United States

  • Icahn School at Mount Sinai, Department of Medicine, Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, New York City, USA

  • Janssen Research and Development, Janssen Biotech, Johnson and Johnson, Spring House, USA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • Anti-Müllerian hormone

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved